Viewing StudyNCT01065246



Ignite Creation Date: 2024-05-05 @ 10:14 PM
Last Modification Date: 2024-10-26 @ 10:16 AM
Study NCT ID: NCT01065246
Status: COMPLETED
Last Update Posted: 2012-10-03
First Post: 2010-01-13

Brief Title: Safety Study of Second Intraperitoneal IP Infusion Cycle of Catumaxomab in Patients With Malignant Ascites
Sponsor: Neovii Biotech
Organization: Neovii Biotech

Conditions & Keywords Data

Conditions:
Name
Malignant Ascites Due to Epithelial Carcinoma
Keywords:
Name View
malignant ascites View
second cycle View
trifunctional View